The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Overview and Growth Trends

• Market Size and Growth: The pharmaceutical gelatin market has shown strong growth, increasing from $1.21 billion in 2023 to $1.3 billion in 2024, with a CAGR of 6.8%. It is projected to reach $1.67 billion by 2028, growing at a CAGR of 6.5%.
• Drivers of Growth: Expansion of the pharmaceutical industry, preference for capsule dosage forms, increasing health awareness, and rising demand for halal and kosher gelatin are key factors driving market expansion.
• Forecasted Trends: Surge in nutraceutical demand, aging population demographics, sustainability practices, global pharmaceutical industry growth, and biodegradable capsules adoption are trends shaping future growth.

Pharmaceutical Gelatin Market Surges With Rising Health and Wellness Demand

The increasing focus on health and wellness is driving growth in the pharmaceutical gelatin market:

• Health and Wellness Demand: Rising awareness and expenditure in the health and wellness sector, expected to reach $7.2 trillion by 2025, are boosting the demand for pharmaceutical gelatin as a crucial component in drug delivery systems.

Key Players in the Market

• Major Companies: Nitta Gelatin Inc., Lonza Group AG, Darling Ingredients Inc., Catalent Inc., and others dominate the pharmaceutical gelatin market, offering diverse product portfolios and global market presence.

Read More On The Pharmaceutical Gelatin Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pharmaceutical-gelatin-global-market-report

Revolutionizing Softgel Production: Easyseal Gelatin Introduces Advanced Solutions

Innovations in gelatin technology are enhancing production efficiency and product performance:

• Easyseal Gelatin: Introduced by GELITA MEDICAL GmbH, it optimizes softgel capsule sealing with enhanced seam stability and reduced production costs, especially beneficial for challenging fill materials.

Darling Ingredients Expands Global Footprint With Gelnex Acquisition

Strategic acquisitions are bolstering market presence and production capabilities:

• Gelnex Acquisition: Darling Ingredients Inc. acquired Gelnex Gelatin to meet growing collagen demands, strengthening its position in the pharmaceutical gelatin market.

Market Segmentation

The pharmaceutical gelatin market is segmented based on type, function, source, and application:

• Type: Type A and Type B.
• Function: Stabilizing Agent, Thickening Agent, Gelling Agent, and others.
• Source: Porcine, Bovine Skin, Bovine Bone, Marine, Poultry.
• Application: Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and other pharmaceutical applications.

Regional Insights

• North America: Largest market in 2023, driven by advanced healthcare infrastructure and high consumer demand for healthcare products.
• Asia-Pacific: Expected to witness the fastest growth, attributed to expanding pharmaceutical industries and increasing healthcare expenditures.

In conclusion, the pharmaceutical gelatin market continues to expand rapidly, driven by technological advancements, demographic shifts, and increasing consumer preference for health-conscious products. With innovations in gelatin production and strategic acquisitions strengthening market positions, the future outlook for the pharmaceutical gelatin industry remains optimistic, poised for sustained growth across global markets.

Request for A Sample Of The Global Pharmaceutical Gelatin Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13911&type=smp